Table 1. Patient, Donor, and Transplant Characteristics.

Characteristic	No. (%)
Patient age, median (range), y	31 (17-56)
Men	27 (65.9)
Male donor	20 (48.8)
Haploidentical donor	32 (78.0)
HLA-matched relative	9 (22.0)
Donor-recipient gender
FF	9 (22.0)
MM	19 (46.3)
FM	10 (24.4)
MF	3 (7.3)
Stem cell source
PBSC	41 (100)
Diagnosis
ALL	18 (43.9)
AML	17 (41.5)
Other	6 (14.6)
Disease status at transplant
CR	37 (90.2)
PR	2 (4.9)
Progressive	2 (4.8)
Conditioning regimen
MAC	40 (97.6)
RIC	1 (2.4)
Use of ATG
Yes	32 (78.0)
No	9 (22.0)
Prior acute graft-vs-host disease
No	8 (19.5)
Grade I to II	21 (51.2)
Grade III to IV	12 (29.3)

Abbreviations: ALL, acute lymphoid leukemia; AML, acute myeloid leukemia; ATG, antithymoglobuline; CR, complete remission; FF, female to female; FM, female to male; HLA, human leukocyte antigen; MAC, myeloablative conditioning; MF, male to female; MM, male to male; PBSC, peripheral blood stem cell; PR, partial remission; RIC, reduced intensity conditioning.